Baird Capital Portfolio Company Apervita Secures $22 Million Investment

Baird Capital portfolio company Apervita, the leading platform for value-based collaboration in healthcare, today announced that it secured $22 million in incremental investment to further accelerate its growth. The announcement comes on the heels of the merger between Apervita and Qcentive and the appointment of industry veteran Kevin Hutchinson as CEO, both of which occurred in the third quarter of 2019.

For more information on this investment, the press release is available here.